Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2023
- Initial findings of HDP-101 presented at ASH Annual Meeting
- Signing of a partnership with Binghamton University
- Termination agreement signed with Magenta
- Financials in line with planning
Heidelberg Pharma AG today reported on the first three months of fiscal year 2023 (1 December 2022 – 28 February 2023) and the Group’s financial figures.